It was reported that thrombosis of the study stent occurred.The patient underwent treatment with the eluvia device on (b)(6) 2017 as part of the eminent clinical trial.The target lesion, located in the left distal superficial femoral artery (sfa), had a 6mm reference vessel diameter proximally and distally.The lesion had a total length of 40mm.The target lesion was 100% occluded and crossed subintimal.Pre-dilatation was performed using a 5.0 mm balloon after which a 6x100mm eluvia stent was implanted.Post-dilatation was performed using a 5.0mm balloon.Residual stenosis was 40%.On (b)(6) 2019, thrombosis of the left sfa and the study stent was observed.The patient had a prickle sensation in the left leg and sensation of cold in the left toe for two weeks.The patient had a walking distance over 300 meters.Conservative treatment was planned and the event is reported as ongoing.
|